|
|
| MRD / Regn No. |
: THBC\23-24\05691 |
Date |
: 10/06/2026 |
| Patient Name |
: Surinder Sachdeva |
Age & Gender |
: 62 Yrs. / Male |
| Contact No. |
: 8398981121 |
UHID |
: |
| Ht / Wt / BMI |
: 166 / 78.8 / 28.60 |
BP S / BP D |
: 105 / 76 |
| Allergies |
: NONE |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM (26/Nov/2018) | |
|
Subjective |
: |
T2DM SINCE 2018,CHRONIC PANCREATITIS / CLD / REC UTI / CKD,LEFT SCIATICA,ENZAR HS - ACIDITY SETTLED,GLP1 ANALOGS - PANCREATITIS / ACIDITY,AFTER LSM - SUGARS DROPPED FROM 150 TO 100 / PPBS 250/300 TO 200 MG,BURNING BETTER / NUMBNESS+ |
|
Objective |
: |
04-JUN-2026 REPORTS,HB-11.8,ALT-15/ AST-17,ACR-420.60,CR-2.16,N129/ K-5.57/ CL-97,HBA1C-7.9% |
|
Analysis |
: |
TAMSULOSIN / HALOPERIDOL / SOBISIS / ZOLFRESH / CRANAC D / EPTOIN / CORTEL LN / SAZO / ZONALTA |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TRESIBA |
SC |
0-0-0-15 |
BEDTIME
|
30 DAYS |
|
|
2 |
PREGABA 75 MG |
ORAL |
1-0-1-0 |
ABF / EVENING 7 PM
|
TO CONTINUE |
|
|
3 |
TABLET DULOXETINE 20 MG
DULANE 20 MG |
ORAL |
0-1-0 |
AL
|
TO CONTINUE |
|
|
4 |
DOLO 500 |
ORAL |
1-0-1 |
ABF / AD
|
3-5 DAYS |
|
|
5 |
EPTOIN 100 MG |
ORAL |
1-0-1 |
ABF / AD
|
TO CONTINUE |
|
|
6 |
SOBISIS FORTE |
ORAL |
1-0-1 |
ABF/AD
|
TO CONTINUE |
|
|
7 |
CORTEL LN 40 |
ORAL |
1-0-1 |
ABF / AD
|
TO CONTINUE |
|
|
8 |
URIMAX 0.4 MG |
ORAL |
0-0-1 |
AD
|
TO CONTINUE |
|
|
9 |
BILYSPA 4 MG |
ORAL |
0-0-1 |
AD
|
TO CONTINUE |
|
|
10 |
AMARYL 2 MG |
ORAL |
1-0-0 |
BEFORE BREAKFAST
|
TO CONTINUE |
|
|
11 |
NEBISTAR 2.5 MG |
ORAL |
1-0-0 |
ABF
|
TO CONTINUE |
|
|
12 |
HUMALOG U 200 |
SC |
10-18-20-15 |
BEFORE EACH MEAL 15-20 MINS
|
30 DAYS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL. |
| Next Visit |
: 10/Jul/2026 |
| Tests Suggested For Next Visit |
: FBS / PPBS / HBA1C > 30 DAYS |
| |
|
| |
|
|
